Aurora Cannabis Doubles Down on Global Medical Market as Q3 Profits Climb
Aurora Cannabis reports a 7% rise in Q3 revenue, fueled by record international medical cannabis sales. The company announces a strategic pivot to exit lower-margin Canadian consumer operations, betting big on high-growth regulated markets in Europe and Australia.